Dr. Philip Scheltens

Dr. Philip Scheltens is Professor of Cognitive Neurology and the Director of the Alzheimer Center at the VU University Medical Center in Amsterdam. He is also the initiator and Vice President of Deltaplan Dementia Netherlands.

His main clinical and research interests are Alzheimer’s disease, vascular dementia, frontotemporal dementia, magnetic resonance imaging, PET imaging and biomarkers for disease detection and early diagnosis. He is active in the field of biomarkers and clinical trials and has been the national Primary Investigator for many trials, including phase 1-3 multicenter clinical trials.

Dr. Scheltens received his MD in 1984 and his PhD in 1993 from the VU University in Amsterdam. His area of focus during his graduate studies was in magnetic resonance imaging in Alzheimer’s disease.  He completed his medical residencies in neurosurgery at the Municipal Hospital Slotervaart and at the VU University Medical Center in Amsterdam.

He holds over 710 publications to his name and has authored more than 50 book chapters. As the Director of the Alzheimer Center, he has supervised over 50 graduate theses.

Dr. Scheltens is an active collaborator and contributor to many fields and is currently a member of various research societies including the International Psychogeriatric Association, the Dutch Society for Neurology, the American Academy of Neurology, the Alzheimer Imaging Consortium, the ISTAART Consortium, and the VASCOG of which he has been the treasurer for many years and is now member of the organizing committee for the VASCOG conference 2016 in Amsterdam.

In addition to this Dr. Scheltens has played an active role in in organizing several national and international conferences including the Imaging symposium at ICAD (now AAIC), and has acted as a chair of the dementia panel of the European Academy of Neurology, for which he now is a member of the program committee.  Dr. Scheltens has been an editor for the Journal of Neurology, Neurosurgery and Psychiatry and now is co-editor-in-chief of Alzheimer Research and Therapy.